EUVIMEDEUVIMED entdecken
Leitlinie

ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- versus -host disease in adults

Saskia Bos iD, John Murray, Monia Marchetti, Guang-Shing Cheng, Anne Bergeron, Daniel Wolff, Clare Sander, Akshay Sharma iD, Sherif M Badawy, Zinaida Peric, Agnieszka Piekarska, Joseph Pidala und 11 weitere

European Respiratory Journal · 2024-03 · 63 (3) · 2301727

DOI: 10.1183/13993003.01727-2023 ↗

Kurz gefasst

Leitlinie in der Zeitschrift European Respiratory Journal, online erschienen am 14.03.2024. Verfasst von Saskia Bos und 22 weiteren Autor:innen. Beteiligte Einrichtung: Dept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Lung Transplantation. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 134 Literaturangaben. Gefördert von: European Respiratory Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic graft- versus -host disease (cGvHD) is a common complication after allogeneic haematopoietic stem cell transplantation, characterised by a broad disease spectrum that can affect virtually any organ. Although pulmonary cGvHD is a less common manifestation, it is of great concern due to its severity and poor prognosis. Optimal management of patients with pulmonary cGvHD is complicated and no standardised approach is available. The purpose of this joint European Respiratory Society (ERS) and European Society for Blood and Marrow Transplantation task force was to develop evidence-based recommendations regarding the treatment of pulmonary cGvHD phenotype bronchiolitis obliterans syndrome in adults. A multidisciplinary group representing specialists in haematology, respiratory medicine and methodology, as well as patient advocates, formulated eight PICO (patient, intervention, comparison, outcome) and two narrative questions. Following the ERS standardised methodology, we conducted systematic reviews to address these questions and used the Grading of Recommendations Assessment, Development and Evaluation approach to develop recommendations. The resulting guideline addresses common therapeutic options (inhalation therapy, fluticasone-azithromycin-montelukast, imatinib, ibrutinib, ruxolitinib, belumosudil, extracorporeal photopheresis and lung transplantation), as well as other aspects of general management, such as lung functional and radiological follow-up and pulmonary rehabilitation, for adults with pulmonary cGvHD phenotype bronchiolitis obliterans syndrome. These recommendations include important advancements that could be incorporated in the management of adults with pulmonary cGvHD, primarily aimed at improving and standardising treatment and improving outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchiolitis Obliterans SyndromeGraft vs Host DiseaseHematopoietic Stem Cell TransplantationLung TransplantationAdultHumansLungChronic Disease

Autor:innen und Institutionen

  • Dept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
  • Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Dept of Haematology and Transplant Unit, Christie Hospital NHS Foundation Trust, Manchester, UK.
  • Dept of Haematology, Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
  • Division of Clinical Research, Fred Hutchinson Cancer Research Center and Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Washington, Seattle, WA, USA.
  • Dept of Pulmonology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.

ORCID-Profile: Saskia Bos, Akshay Sharma, Courtney Coleman, Robin Vos

Förderung

  • European Respiratory Society

Zitieren

APA

Bos, S., Murray, J., Marchetti, M., Cheng, G. S., Bergeron, A., Wolff, D., Sander, C., Sharma, A., Badawy, S. M., Peric, Z., Piekarska, A., Pidala, J., Raj, K., Penack, O., Kulkarni, S., Beestrum, M., Linke, A., Rutter, M., Coleman, C., …, & Vos, R. (2024). ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- versus -host disease in adults. European Respiratory Journal, 63(3), 2301727. https://doi.org/10.1183/13993003.01727-2023

Vancouver

Bos S, Murray J, Marchetti M, Cheng GS, Bergeron A, Wolff D, et al. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- versus -host disease in adults. European Respiratory Journal. 2024;63(3):2301727. doi:10.1183/13993003.01727-2023

BibTeX
@article{Bos2024,
  author = {Bos, Saskia and Murray, John and Marchetti, Monia and Cheng, Guang-Shing and Bergeron, Anne and Wolff, Daniel and Sander, Clare and Sharma, Akshay and Badawy, Sherif M and Peric, Zinaida and Piekarska, Agnieszka and Pidala, Joseph and Raj, Kavita and Penack, Olaf and Kulkarni, Samar and Beestrum, Molly and Linke, Andrea and Rutter, Matthew and Coleman, Courtney and Tonia, Thomy and Schoemans, Hélène and Stolz, Daiana and Vos, Robin},
  title = {ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- versus -host disease in adults},
  journal = {European Respiratory Journal},
  year = {2024},
  volume = {63},
  number = {3},
  pages = {2301727},
  doi = {10.1183/13993003.01727-2023}
}
Kostenlos starten →